Bristol-Myers Squibb Company (BMY)
-NYSE 43.30 
0.53(1.24%) May 17, 4:00PM EDT|After Hours
:
43.05 0.25 (0.58%) May 17, 6:41PM EDT
| Prev Close: | 42.77 |
|---|
| Open: | 42.99 |
|---|
| Bid: | 39.75 x 700 |
|---|
| Ask: | 43.54 x 100 |
|---|
| 1y Target Est: | 39.30 |
|---|
| Beta: | 0.12 |
|---|
| Next Earnings Date: | 22-Jul-13 |
|---|
| Day's Range: | 42.70 - 43.43 |
|---|
| 52wk Range: | 30.64 - 45.59 |
|---|
| Volume: | 11,130,086 |
|---|
| Avg Vol (3m): | 9,887,900 |
|---|
| Market Cap: | 71.12B |
|---|
| P/E (ttm): | 49.04 |
|---|
| EPS (ttm): | 0.88 |
|---|
| Div & Yield: | 1.40 (3.20%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Pick Your Poison: Overweight or High Cholesterolat Motley Fool(Sun 11:00AM EDT)
- PRESS DIGEST - Sunday British business - May 19at Reuters(Sun 8:11AM EDT)
- 1 Giant Leap for MannKindat Motley Fool(Sat, May 18)
- Oncothyreon A Speculative Buyat Seeking Alpha(Fri, May 17)
- Final Glance: Pharmaceuticals companiesAP(Fri, May 17)
- Bristol-Myers Squibb Company (BMY): Today's Featured Drugs Winnerat TheStreet(Fri, May 17)
- Midday Glance: Pharmaceuticals companiesAP(Fri, May 17)
- Early Glance: Pharmaceuticals companiesAP(Fri, May 17)
- Analysts' Actions: AMAT ARUN BMY DE WSMTheStreet(Fri, May 17)
- Bristol-Myers, Merck And Roche: R&D Finds Golden Pill, So Buyat Seeking Alpha(Fri, May 17)
- [$$] AbbVie Is Good Medicineat Barrons.com(Thu, May 16)
- Cheerleaders: Look Beyond Pharma For JobsYCharts(Thu, May 16)
- Bristol-Myers Squibb Announces Intention to Voluntarily Delist Preferred StockBusiness Wire(Thu, May 16)
- Bristol-Myers Drug Cocktail Stymies Melanoma Tumorsat Bloomberg(Thu, May 16)
- [video] Biotech's Next Big Thing -- ASCO IIat TheStreet(Thu, May 16)
Key Statistics
| Forward P/E (1 yr): | 20.33 |
|---|
| P/S (ttm): | 4.34 |
|---|
| Ex-Dividend Date: | 03-Apr-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 1.81 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.44 |
|---|
| Mean Recommendation*: | 2.4 |
|---|
| PEG Ratio (5 yr expected): | 2.49 |
|---|
Business Summary
Bristol-Myers Squibb Company, a biopharmaceutical company, discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products that help patients prevail over serious diseases worldwide.
View More